SMYD5 and lung adenocarcinoma: Specifically, SMYD5 exhibited a mutation frequency of 2.3% in colorectal cancer, while SMYD1 demonstrated a mutation frequency of 2.3% in both lung adenocarcinoma and lung squamous cell carcinoma.